Tremor in idiopathic distal acquired demyelinating symmetric neuropathy

Movement Disorders

Volumn 20, Issue 11, 2005, Pages 1529-1530

  Budak, Faik ^a   Alemdar, Murat ^a   Kamaci, Senol ^a   Selekler, Macit ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISONE; PRIMIDONE;

AGED; ANAMNESIS; BRAIN ELECTROPHYSIOLOGY; CASE REPORT; CLINICAL PROTOCOL; DEMYELINATING NEUROPATHY; DRUG EFFICACY; DRUG WITHDRAWAL; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; LETTER; MALE; MUSCLE WEAKNESS; NERVE BIOPSY; NERVE CONDUCTION; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; SCORING SYSTEM; SURAL NERVE; TREMOR;

AGED; ANTICONVULSANTS; DEMYELINATING DISEASES; FUNCTIONAL LATERALITY; HUMANS; MALE; NEURAL CONDUCTION; PERIPHERAL NERVOUS SYSTEM DISEASES; PRIMIDONE; SEVERITY OF ILLNESS INDEX; TREMOR;

EID: 30444438770     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.20693     Document Type: Letter

References (15)

1. Louis ED, Shungu DC, Mao X, Chan S, Jurewicz EC. Cerebellar metabolic symmetry in essential tremor studied with 1H magnetic resonance spectroscopic imaging: implications for disease pathology. Mov Disord 2004;19:672-677.
2. Ruzicka E, Jech R, Zarubova K, Roth J, Urgosik D. VIM thalamic stimulation for tremor in a patient with IgM paraproteinaemic demyelinating neuropathy. Mov Disord 2003;18:1192-1195.
3. Saverino A, Solaro C, Capello E, et al. Tremor associated with benign IgM paraproteinaemic neuropathy successfully treated with gabapentin. Mov Disord 2001;16:967-968.
4. Saperstein DS, Katz JS, Amato AA, Barohn RJ. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 2001;24:311-324.
5. Katz JS, Saperstein DS, Gronseth G, Amato AA, Barohn RJ. Distal acquired demyelinating symmetric neuropathy. Neurology 2000; 54:615-620.
6. Melmed C, Frail D, Duncan I, et al. Peripheral neuropathy with IgM kappa monoclonal immunoglobulin directed against myelin-associated glycoprotein. Neurology 1983;33:1397-1405.
7. Dalakas MC, Teravainen H, Engel WK. Tremor as a feature of chronic relapsing and dysgammaglobulinemic polyneuropathies. Incidence and management. Arch Neurol 1984;41:711-714.
8. Said G, Bathien N, Cesaro P. Peripheral neuropathies and tremor. Neurology 1982;32:480-485.
9. Pedersen SF, Pullman SL, Latov N, Brannagan TH III. Physiological tremor analysis of patients with anti-myelin-associated glycoprotein associated neuropathy and tremor. Muscle Nerve 1997;20: 38-44.
10. Busby M, Nithi K, Mills K, Donaghy M. The tremor associated with non-paraproteinaemic acquired demyelinating polyneuropathy-a case study. J Neurol 2003;250:486-487.
11. Bain PG, Britton TC, Jenkins IH, et al. Tremor associated with benign IgM paraproteinaemic neuropathy. Brain 1996;119(Pt 3): 789-799.
12. Bain PG. The management of tremor. J Neurol Neurosurg Psychiatry 2002;72(Suppl. 1):I3-I9.
13. Marsden CD. Origins of normal and pathological tremor. In: Findley LJ, Capildeo R, editors. Movement disorders: tremor. New York: Oxford University Press; 1988. p 37-84.
14. Gorman WP, Cooper R, Pocock P, Campbell MJ. A comparison of primidone, propranolol, and placebo in essential tremor, using quantitative analysis. J Neurol Neurosurg Psychiatry 1986;49:64-68.
15. Wills AJ, Jenkins IH, Thompson PD, et al. Red nuclear and cerebellar but no olivary activation associated with essential tremor: a positron emission tomographic study. Ann Neurol 1994;36: 636-642.